Surgery guidance using a special lung cancer navigation scan
Part of Cancer, Lungs & breathing clinical trials.
This trial tests whether a special navigation system during lung cancer surgery (using SERS technology) can help surgeons better locate and remove lung tumor tissue. You may be able to take part if you are having surgery to remove the tumor and meet the study’s timing and health requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You agree to join, understand the study, and sign consent
- You are between 18 and 75 years old when you sign
- You are having surgery that removes the lung tumor with at least a 2 cm surgical margin
- The areas being measured during surgery are larger than 0.5 cm
- You have not had any previous cancer treatment with pills or other body-wide therapy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a new surgical robot that uses only one small opening in the chest to remove a lung segment or lobe. It aims to see if the robot is safe and effective for patients who need this type of surgery.
This trial uses a special navigation system to place tiny markers next to lung nodules before surgery. This helps surgeons find and remove the nodule more precisely.
This study tests a new system called EAS1 for people with early-stage lung cancer who are already scheduled for surgery. The goal is to see if the device is safe and works well, and it may offer a less invasive way to remove small lung tumors.
This trial tests a new way to help surgeons find the right boundary between lung segments during surgery, using oxygen levels to guide them. It may help patients with small, early-stage lung tumors.
This study collects information from people having surgery to remove a small part of the lung (segmentectomy) for early-stage lung cancer. It helps doctors learn more about this surgery and its outcomes.
This trial studies a comprehensive treatment approach for lung cancer that combines immunotherapy given before surgery with standard surgery. It aims to understand how well this approach works by analyzing your medical data and samples.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.